arrow
W

Wang-Zhong Li

sun yatsen university
H指数:20
被引数:3,631

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Integrated Multiomic Analysis Reveals an EBV‐Associated MIF–SPP1 + Macrophage Axis Linking Tumor Stemness and Immune Dysfunction in Nasopharyngeal Carcinoma

整合多组学分析揭示EBV相关MIF–SPP1 <sup>+</sup> 巨噬细胞轴连接鼻咽癌的肿瘤干性与免疫功能障碍

2026-10-310
PRE
LcProt: Proteomics-based identification of plasma biomarkers for lung cancer multievent, a multicentre study

LcProt:基于蛋白质组学的血浆生物标志物鉴定,用于肺癌多事件研究,一项多中心研究

2025-01-091
OAAI
Single-cell transcriptome analysis reveals evolving tumour microenvironment induced by immunochemotherapy in nasopharyngeal carcinoma

单细胞转录组分析揭示了鼻咽癌中免疫化学疗法诱导的不断变化的肿瘤微环境

2024-10-160
OAAI
Nab-paclitaxel, cisplatin, and capecitabine versus cisplatin and gemcitabine as first line chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma: randomised phase 3 clinical trial
2024-06-192
OAAI
Efficacy and safety of sintilimab plus bevacizumab in metastatic nasopharyngeal carcinoma after failure of platinum-based chemotherapy: an open-label phase 2 study

sintilimab联合贝伐单抗治疗铂类化疗失败后转移性鼻咽癌的疗效和安全性: 一项开放标签2期研究

2023-08-016
OAAI
Prediction model for the pretreatment evaluation of mortality risk in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with interstitial lung disease
2022-09-238
OAAI
A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer
2021-06-0315
OAAI